Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Lotter

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Leukemia|July 27, 2022
Predictors of clonal evolution and myeloid neoplasia following immunosuppressive therapy in severe aplastic anemiaEmma M Groarke, Bhavisha A Patel, Ruba Shalhoub, et al.
Blood|January 5, 2017
Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemiaInhye E Ahn, Chingiz Underbayev, Adam Albitar, et al.
Haematologica|December 1, 2020
Eltrombopag monotherapy can improve hematopoiesis in patients with low to intermediate risk-1 myelodysplastic syndromeAlana Vicente, Bhavisha A Patel, Fernanda Gutierrez-Rodrigues, et al.
Blood Advances|August 24, 2021
Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1Ifeyinwa Emmanuela Obiorah, Bhavisha A Patel, Emma M Groarke, et al.
NEJM Evidence|April 28, 2026
Clonal Selection and Evolution after Treatment of Severe Aplastic AnemiaFernanda Gutierrez-Rodrigues, Emma M Groarke, Rui Miao, et al.
Leukemia & Lymphoma|March 3, 2021
Risk-adapted, ofatumumab-based chemoimmunotherapy and consolidation in treatment-naïve chronic lymphocytic leukemia: a phase 2 studySanjal Desai, Clifton Mo, Erika M Gaglione, et al.
Blood|February 28, 2018
Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 studyInhye E Ahn, Mohammed Z H Farooqui, Xin Tian, et al.
British Journal of Haematology|September 21, 2022
Clinical outcomes and immune responses to SARS-CoV-2 vaccination in severe aplastic anaemiaRoma V Rajput, Xiaoyang Ma, Kristin L Boswell, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Leukemia|July 27, 2022
Predictors of clonal evolution and myeloid neoplasia following immunosuppressive therapy in severe aplastic anemiaEmma M Groarke, Bhavisha A Patel, Ruba Shalhoub, et al.
Blood|January 5, 2017
Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemiaInhye E Ahn, Chingiz Underbayev, Adam Albitar, et al.
Haematologica|December 1, 2020
Eltrombopag monotherapy can improve hematopoiesis in patients with low to intermediate risk-1 myelodysplastic syndromeAlana Vicente, Bhavisha A Patel, Fernanda Gutierrez-Rodrigues, et al.
Blood Advances|August 24, 2021
Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1Ifeyinwa Emmanuela Obiorah, Bhavisha A Patel, Emma M Groarke, et al.
NEJM Evidence|April 28, 2026
Clonal Selection and Evolution after Treatment of Severe Aplastic AnemiaFernanda Gutierrez-Rodrigues, Emma M Groarke, Rui Miao, et al.
Leukemia & Lymphoma|March 3, 2021
Risk-adapted, ofatumumab-based chemoimmunotherapy and consolidation in treatment-naïve chronic lymphocytic leukemia: a phase 2 studySanjal Desai, Clifton Mo, Erika M Gaglione, et al.
Blood|February 28, 2018
Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 studyInhye E Ahn, Mohammed Z H Farooqui, Xin Tian, et al.
British Journal of Haematology|September 21, 2022
Clinical outcomes and immune responses to SARS-CoV-2 vaccination in severe aplastic anaemiaRoma V Rajput, Xiaoyang Ma, Kristin L Boswell, et al.
Pageof 3